基本信息
浏览量:125
职业迁徙
个人简介
In the laboratory, his group recently led a team of four major laboratories at Yale, which reported the stunning discovery that IDH1/2-mutant tumors harbor a profound DNA repair defect that renders them exquisitely sensitive to PARP inhibitors. This work was published in Science Translational Medicine, and Nature, and it has received international attention with major clinical implications Dr. Bindra is now translating this work directly into patients, in four phase I/II clinical trials, including an innovative, biomarker-driven trial specifically targeting the Adolescent/Young Adult (AYA) cancer patient population. In addition, he is lead co-PI of a 35-site, NCI-sponsored Phase II trial testing the PARP inhibitor, olaparib, in adult IDH1/2-mutant solid tumors (NCT03212274). As a biotech entrepreneur he recently co-founded Cybrexa Therapeutics, a Series B round-funded company focused on developing an entirely new class of small molecule DNA repair inhibitors, which directly target the tumor microenvironment. Dr. Bindra received his undergraduate degree in Molecular Biophysics and Biochemistry from Yale University in 1998, and both his MD and PhD from the Yale School of Medicine in 2007. He completed his medical internship, radiation oncology residency, and post-doctoral research studies at the Memorial Sloan-Kettering Cancer Center (MSKCC) in 2012.
研究兴趣
论文共 263 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Prateek Bhardwaj,Ranjini Sundaram, Amro Baassiri, Martin Matthews,Jennifer VanOudenhove,Susan Gueble,Stephanie Halene,Ranjit Bindra
Cancer Researchno. 6_Supplement (2024): 7123-7123
Katelyn J. Noronha, Karlie N. Lucas, Sophia J. Zhao, Joseph Edmonds, Sam Friedman, Matthew A. Murray, Samantha Liu,Jiayu Liang,Sateja Paradkar,Hao Zeng,Ranjini K. Sundaram, Josh Spurrier,
Cancer Researchno. 6_Supplement (2024): 3086-3086
Alexander Josowitz,Teresa Lee,Ranjini K. Sundaram,Jinal Pothupitiya, Eric J. Brown,Amrita Sule,Jason Beckta,Yongheng Wang, Joseph Vacca,Oren Gilad,Ranjit S. Bindra,W Mark Saltzman
Cancer Researchno. 6_Supplement (2024): 7117-7117
Sophia J. Zhao, Katelyn J. Noronha, Prateek Bhardwaj, Karlie N. Lucas,Ranjini K. Sundaram, Collin D. Heer, Raffaella Morotti, Josh Spurrier, Mitch Raponi,Ranjit S. Bindra,Juan C. Vasquez
Cancer Researchno. 6_Supplement (2024): 2866-2866
crossref(2023)
Science translational medicineno. 720 (2023): eadi1617-eadi1617
Bruce Ruggeri, Kyle Tarantino,Ranjini K. Sundaram,Kingson Lin,Seth B. Herzon,Joseph Park, Spenser Johnson,Susan Gueble,Ranjit S. Bindra
Cancer Researchno. 7_Supplement (2023): 1132-1132
引用0浏览0引用
0
0
Ranjit S. Bindra, Shannon L. Gibson,Alice Meng, Ulrica Westermark,Maria Jasin,Andrew J. Pierce,Robert G. Bristow, Marie K. Classon,Peter M. Glazer
crossref(2023)
Christopher B. Jackson,Seth I. Noorbakhsh,Ranjini K. Sundaram, Aravind N. Kalathil,Sachita Ganesa, Lanqi Jia, Hank Breslin,Danielle M. Burgenske, Oren Gilad,Jann N. Sarkaria,Ranjit S. Bindra
crossref(2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn